Tolerance and efficacy of HIFU ablation for uterine fibroids NPVR ≥ 90%: a nested case-control study

References

• Stewart E, Cookson C, Gandolfo R, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–1512.
   PubMed Web of Science ®Google Scholar
• Faustino F, Martinho M, Reis J, et al. Update on medical treatment of uterine fibroids. Eur J Obstet Gynecol Reprod Biol. 2017;216:61–68.
   PubMed Web of Science ®Google Scholar
• Silberzweig JE, Powell DK, Matsumoto AH, et al. Management of uterine fibroids: a focus on uterine-sparing interventional techniques. Radiology. 2016;280(3):675–692.
   PubMed Web of Science ®Google Scholar
• Ciebiera M, Łoziński T, Wojtyła C, et al. Complications in modern hysteroscopic myomectomy. Ginekol Pol. 2018;89(7):398–404.
   PubMed Web of Science ®Google Scholar
• Abbas AM, Michael A, Ali SS, et al. Spontaneous prelabour recurrent uterine rupture after laparoscopic myomectomy. J Obstet Gynaecol. 2018;38(7):1033–1034.
   PubMedGoogle Scholar
• Toor SS, Jaberi A, Macdonald DB, et al. Complication rates and effectiveness of uterine artery embolization in the treatment of symptomatic leiomyomas: a systematic review and meta-analysis. AJR Am J Roentgenol. 2012;199(5):1153–1163.
   PubMed Web of Science ®Google Scholar
• Feng Y, Hu L, Chen W, et al. Safety of ultrasound-guided high-intensity focused ultrasound ablation for diffuse adenomyosis: a retrospective cohort study. Ultrason Sonochem. 2017;36:139–145.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang ZB, Xu YH. Efficacy, efficiency, and safety of magnetic resonance-guided high-intensity focused ultrasound for ablation of uterine fibroids: comparison with ultrasound-guided method. Korean J Radiol. 2018;19(4):724–732.
   PubMed Web of Science ®Google Scholar
• Keserci B, Duc NM, Nadarajan C, et al. Volumetric MRI-guided, high-intensity focused ultrasound ablation of uterine leiomyomas: ASEAN preliminary experience. Diagn Interv Radiol. 2020;26(3):207–215.
   PubMed Web of Science ®Google Scholar
• Qin J, Chen JY, Zhao WP, et al. Outcome of unintended pregnancy after ultrasound-guided high-intensity focused ultrasound ablation of uterine fibroids. Int J Gynaecol Obstet. 2012;117(3):273–277.
   PubMed Web of Science ®Google Scholar
• Keserci B, Duc NM. Magnetic resonance imaging parameters in predicting the treatment outcome of high-intensity focused ultrasound ablation of uterine fibroids with an immediate nonperfused volume ratio of at least 90%. Acad Radiol. 2018;25(10):1257–1269.
   PubMed Web of Science ®Google Scholar
• Yang MJ, Yu RQ, zhi CW, et al. A prediction of NPVR ≥ 80% of ultrasound-guided high-intensity focused ultrasound ablation for uterine fibroids. Front Surg. 2021;8:663128.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Wang Z, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. BJOG: Int J Obstet Gy. 2018;125(3):354–364.
   PubMed Web of Science ®Google Scholar
• Orsini LF, Salardi S, Pilu G, et al. Pelvic organs in premenarcheal girls: real-time ultrasonography. Radiology. 1984;153(1):113–116.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Funaki T, et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol. 2007;196(2):184.e1.
   PubMedGoogle Scholar
• Goodwin SC, Bonilla SC, Sacks D, et al. Reporting standards for uterine artery embolization for the treatment of uterine leiomyomata. J Vasc Interv Radiol. 2003;14(9 Pt 2):S467–S476.
   PubMed Web of Science ®Google Scholar
• Spies JB, Coyne K, Guaou Guaou N, et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002;99(2):290–300.
   PubMed Web of Science ®Google Scholar
• Froeling V, Meckelburg K, Schreiter NF, et al. Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. Eur J Radiol. 2013;82(12):2265–2269.
   PubMed Web of Science ®Google Scholar
• Cheung VYT. High-intensity focused ultrasound therapy. Best Pract Res Clin Obstet Gynaecol. 2018;46:74–83.
   PubMed Web of Science ®Google Scholar
• Verpalen IM, Anneveldt KJ, Nijholt IM, et al. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: a systematic review and meta-analysis. Eur J Radiol. 2019;120:108700.
   PubMed Web of Science ®Google Scholar
• Fauconnier A, Chapron C, Babaki-Fard K, et al. Recurrence of leiomyomata after myomectomy. Hum Reprod Update. 2000;6(6):595–602.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Gostout B, Rabinovici J, et al. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007;110(6):1428–1428.
   Web of Science ®Google Scholar
• Hanafi M. Predictors of leiomyoma recurrence after myomectomy. Obstet Gynecol. 2005;105(4):877–881.
   PubMed Web of Science ®Google Scholar
• Park MJ, Kim Y s, Rhim H, et al. Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging–guided High-Intensity focused US therapy. J Vasc Interv Radiol. 2014;25(2):231–239.
   PubMed Web of Science ®Google Scholar
• Kröncke T, David M. MR-Guided focused ultrasound in fibroid treatment – results of the 4th radiological-gynecological expert meeting. Rofo. 2019;191(7):626–629.
   PubMedGoogle Scholar
• Yin N, Hu L, Xiao ZB, et al. Factors influencing thermal injury to skin and abdominal wall structures in HIFU ablation of uterine fibroids. Int J Hyperthermia. 2018;34(8):1298–1303.
   PubMed Web of Science ®Google Scholar